Ellison Rr
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Oncology 4
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 1
-
- Acute Lymphoblastic Leukemia research 4
Ellison Rr
9 papers receiving 290 citations
Peers
Comparison fields: 5 of 47
- Hematology 228
- Genetics 49
- Oncology 104
- Public Health, Environmental and Occupational Health 96
- Molecular Biology 128
Countries citing papers authored by Ellison Rr
This map shows the geographic impact of Ellison Rr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellison Rr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellison Rr more than expected).
Fields of papers citing papers by Ellison Rr
This network shows the impact of papers produced by Ellison Rr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellison Rr. The network helps show where Ellison Rr may publish in the future.
Co-authors
The 14 scholars most cited alongside Ellison Rr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. | 1974 | 277 |
| 2 | The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report. | 1960 | 18 |
| 3 | Adriamycin (NSC-123127) in the treatment of acute myelocytic leukemia. | 1972 | 10 |
| 4 | Experience with fluorinated pyrimidines in adenocarcinoma of the lower intestinal tract. | 1962 | 7 |
| 5 | Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. | 1972 | 3 |
| 6 | ADULTS WITH ACUTE LEUKEMIA. | 1964 | 2 |
| 7 | CLINICAL PHARMACOLOGIC STUDY OF HADACIDIN (NSC-521778). | 1965 | 1 |
| 8 | Management of disseminated neoplastic disease: hematological problems. | 1957 | 1 |
| 9 | Treatment of chronic granulocytic leukemia with the 6-substituted purines 6-mercaptopurine, thioguanine, and 6-chloropurine. | 1998 | 1 |
About Ellison Rr
Ellison Rr is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Genetics, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 9 papers that have together received 320 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer Treatment and Pharmacology (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Plant-based Medicinal Research (1 paper), Intramuscular injections and effects (1 paper) and Metastasis and carcinoma case studies (1 paper). The work is most often cited by research in Hematology (228 citations), Genetics (49 citations), Oncology (104 citations), Public Health, Environmental and Occupational Health (96 citations) and Molecular Biology (128 citations). Frequent co-authors include Yates Jw, Holland Jf, Wallace Hj, Young Cw, George C. Escher, Edward Miller, Burchenal Jh, Robert A. Kaufman, RN Levy and C Jacquillat. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.